Skip to main content
. Author manuscript; available in PMC: 2010 Nov 1.
Published in final edited form as: Am J Surg Pathol. 2009 Nov;33(11):1683–1694. doi: 10.1097/PAS.0b013e3181b18a89

Figure 2.

Figure 2

Immunophenotype of pleomorphic lobular carcinoma in situ. (Original magnification 400X). A. Absence of staining for E-cadherin (note the positive membranous staining in the adjacent normal ducts); B. Strong cytoplasmic staining demonstrated for GCDFP-15; C. Strong expression of androgen receptor; D. Lack of ER expression (note focal nuclear staining in adjacent normal duct); E. HER2 protein overexpression. F. High Ki-67 labeling index.